Avalo Therapeutics Inc (AVTX)

Mar 02, 2026

Avalo Therapeutics (AVTX) awards 80,000 stock options to Chief Legal Officer - Stock Titan

Mar 02, 2026

Mar 02, 2026

Avalo Therapeutics (AVTX) CSO awarded 95,000 stock options - Stock Titan

Mar 02, 2026

Mar 02, 2026

[Form 4] Avalo Therapeutics, Inc. Insider Trading Activity - Stock Titan

Mar 02, 2026

Mar 02, 2026

Avalo Therapeutics (NASDAQ: AVTX) CBO awarded 95,000 stock options - Stock Titan

Mar 02, 2026

Mar 02, 2026

Avalo Therapeutics (AVTX) CFO awarded 105,000 stock options as equity compensation - Stock Titan

Mar 02, 2026

Mar 02, 2026

Avalo Therapeutics (AVTX) CEO awarded 286,000-share stock option grant - Stock Titan

Mar 02, 2026

Feb 27, 2026

Millennium Management LLC Acquires Additional Shares in Avalo Therapeutics Inc - GuruFocus

Feb 27, 2026

Feb 27, 2026

RWA Wealth Partners LLC Cuts Position in Avalo Therapeutics, Inc. $AVTX - MarketBeat

Feb 27, 2026

Feb 26, 2026

AVTX Should I Buy - Intellectia AI

Feb 26, 2026

Feb 25, 2026

Avalo Therapeutics Highlights AVTX-009 HS Phase II Catalyst, Cash Runway at Oppenheimer Conference - Yahoo Finance

Feb 25, 2026

Feb 25, 2026

AVTX: AVTX-009 targets central HS inflammation, with pivotal phase II data expected next quarter - TradingView

Feb 25, 2026

Feb 24, 2026

TD Cowen reiterates Avalo Therapeutics stock rating citing phase II opportunity - Investing.com South Africa

Feb 24, 2026

Feb 24, 2026

Piper Sandler Initiates Coverage of Avalo Therapeutics (AVTX) with Overweight Recommendation - MSN

Feb 24, 2026

Feb 24, 2026

Avalo Therapeutics to Participate in Upcoming Investor Conferences - Bitget

Feb 24, 2026

Feb 23, 2026

Patient Square Capital LP Makes New Investment in Avalo Therapeutics, Inc. $AVTX - MarketBeat

Feb 23, 2026

Feb 22, 2026

AVTXAvalo Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

Feb 22, 2026

Feb 22, 2026

Aberdeen Group plc Makes New $925,000 Investment in Avalo Therapeutics, Inc. $AVTX - MarketBeat

Feb 22, 2026

Feb 21, 2026

Reviewing Avalo Therapeutics (NASDAQ:AVTX) and VYNE Therapeutics (NASDAQ:VYNE) - Defense World

Feb 21, 2026

Feb 20, 2026

Balyasny Asset Management L.P. Reduces Stake in Avalo Therapeuti - GuruFocus

Feb 20, 2026

Feb 18, 2026

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 18, 2026

Feb 17, 2026

Millennium discloses 4.8% Avalo Therapeutics (AVTX) ownership position - Stock Titan

Feb 17, 2026

Feb 13, 2026

Can Avalo Therapeutics Inc. outperform under higher oil pricesJuly 2025 PreEarnings & Low Risk High Win Rate Picks - mfd.ru

Feb 13, 2026

Feb 13, 2026

Is Avalo Therapeutics Inc. stock overvalued by current metricsJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru

Feb 13, 2026

Feb 13, 2026

How Avalo Therapeutics Inc. stock reacts to global recession fearsWeekly Stock Recap & Community Shared Stock Ideas - mfd.ru

Feb 13, 2026

Feb 13, 2026

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 13, 2026

Feb 11, 2026

Avalo Therapeutics Eyes Q2 2026 Phase IIb LOTUS Readout for AVTX-009 in Hidradenitis Suppurativa - MarketBeat

Feb 11, 2026

Feb 11, 2026

AVTX: Phase 2b LOTUS trial for AVTX-009 in HS nears Q2 data, targeting rapid phase 3 and new indications - TradingView

Feb 11, 2026

Feb 11, 2026

What analysts say about Avalo Therapeutics Inc. stockJuly 2025 Breakouts & AI Driven Price Forecasts - mfd.ru

Feb 11, 2026

Feb 10, 2026

SilverArc Capital and Devesh Gandhi report 2.83% Avalo Therapeutics (AVTX) holding - Stock Titan

Feb 10, 2026

Feb 06, 2026

Dow Update: Will Avalo Therapeutics Inc outperform the market in YEARRate Hike & Long-Term Capital Growth Ideas - baoquankhu1.vn

Feb 06, 2026

Feb 05, 2026

Piper Sandler Keeps Their Buy Rating on Avalo Therapeutics (AVTX) - The Globe and Mail

Feb 05, 2026

Feb 04, 2026

Avalo Therapeutics shares jump as Guggenheim starts coverage with buy - MSN

Feb 04, 2026

Feb 04, 2026

Biotech firm Avalo will stream two investor talks in February - Stock Titan

Feb 04, 2026

Feb 02, 2026

Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case - Benzinga

Feb 02, 2026

Feb 02, 2026

Guggenheim Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - Nasdaq

Feb 02, 2026

Feb 02, 2026

Guggenheim Initiates Coverage on Avalo Therapeutics (AVTX) with - GuruFocus

Feb 02, 2026

Feb 02, 2026

Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating By Investing.com - Investing.com Australia

Feb 02, 2026

Feb 02, 2026

Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating - Investing.com

Feb 02, 2026

Feb 02, 2026

Guggenheim Begins Coverage on Avalo Therapeutics (NASDAQ:AVTX) - MarketBeat

Feb 02, 2026

Feb 02, 2026

Guggenheim initiates Avalo Therapeutics stock with Buy rating on IL-1β therapy - Investing.com UK

Feb 02, 2026

Feb 02, 2026

Guggenheim initiates Avalo Therapeutics stock with Buy rating on IL-1β therapy By Investing.com - Investing.com India

Feb 02, 2026

Feb 02, 2026

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Feb 02, 2026

Jan 29, 2026

Avalo Therapeutics Highlights AVTX-009 Progress in HS - TipRanks

Jan 29, 2026

Jan 26, 2026

Aug Update: Is Avalo Therapeutics Inc in a bullish channelJuly 2025 Short Interest & Expert Curated Trade Setups - baoquankhu1.vn

Jan 26, 2026

Jan 23, 2026

Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study - MSN

Jan 23, 2026

Jan 22, 2026

Patterns Watch: Is Avalo Therapeutics Inc a potential multi bagger2025 Top Gainers & Safe Entry Zone Tips - baoquankhu1.vn

Jan 22, 2026

Jan 22, 2026

Market Pulse: What is the long term forecast for Renovaro Inc stock2025 Geopolitical Influence & Comprehensive Market Scan Reports - baoquankhu1.vn

Jan 22, 2026

Jan 22, 2026

Gainers Report: Can Avalo Therapeutics Inc outperform under higher oil pricesJuly 2025 Price Swings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Jan 22, 2026

Jan 22, 2026

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $32.71 Consensus Price Target from Analysts - Defense World

Jan 22, 2026

Jan 21, 2026

Market Wrap: What is the target price for DXLG stock2025 Retail Activity & AI Based Trade Execution Alerts - baoquankhu1.vn

Jan 21, 2026

Jan 19, 2026

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 19, 2026